Azin Parhizgar

Azin Parhizgar, PhD serves as Managing Director, US and member of the Investment Committee at 415C. A distinguished entrepreneur and medical device industry executive, Azin currently serves as Chairwoman of CVPath Institute. She also serves as an independent board director at CroíValve, InnovHeart and Protembis. Prior to joining 415C, Azin served as CEO, President and Board Member at Claret Medical, a pioneer in the field of cerebral embolic protection. She led Claret Medical through successful clinical trials, US FDA approval and ultimately a $270 Million exit to Boston Scientific. Prior to Claret Medical, Azin served as the Chief Operating Officer of Conor Medsystems where she played a key role in the acquisition of the company by Johnson & Johnson, Inc. for $1.4 Billion in 2007. She spent one-year post-merger with Johnson & Johnson for full integration of the companies. Between 1996-2000 she held the position of Executive Vice President for Arterial Vascular Engineering, which was acquired by Medtronic for $3.7 Billion. She spent two years at Medtronic post-merger in increasing roles of responsibility leading to her role as Executive Vice President of Emerging Ventures and New Technologies. Azin received both her Ph.D. in Cell, Gene and Tissue Engineering and her M.Sc. in Biomechanical Engineering and Artificial Organ Design from Brown University.